AUG 10, 2016 3:14 PM PDT

One Drug to Take Down 3 Deadly Parasites?

WRITTEN BY: Xuan Pham
Pharmaceutical giant Novartis announced drastic and fruitful measures to combat three killer parasites that affect millions of people worldwide. After screening a whopping 3 million chemical compounds, they landed on a single drug that can kill parasites causing sleeping sickness, Chagas disease, and Leishmaniasis.
 
"What makes it special is the fact it is targeting all three parasites. That's the first time it has been done, so it is quite special,” said Elmarie Myburgh, co-author of the study published as a Letter in Nature.
 
Worldwide, around 20 million people are affected with sleeping sickness (via Trypanosoma brucei), Chagas disease (via Trypansosoma cruzi), and Leishmaniasis (via Leishmania). All three parasites share similar biology and genomic sequence, which prompted the quest for a common drug.
 
Indeed, scientists from the Genomics Institute of the Novartis Research Foundation combed through 3 million compounds – no small feat by any stretch of the imagination. Their persistence paid off when they finally found one compound that killed multiple parasites in the lab. Known as GNF6702 for now, the drug targets the parasites’ proteasomes – structures that chew up and recycle damaged or waste proteins in the cells.
 
Even if it can kill all the parasites, a drug is no good if it also kills the host cells indiscriminately. Luckily, in experiments, the team showed the drug inhibits the parasites’ proteasomes without affecting those of mammalian cells.
 
With modifications, the drug was made even more potent – 20 times more potent to be exact. But this seemed to be tolerated with no problem in mice, giving hope that pre-clinical and clinical trials will also show promising results.
 

"To me this is obviously a big deal, I'm in this field to try and make a difference, to get to a cure, and we're working hard in the hope that it gets to patients,” said Myburgh. "There's been very little incentive to spend a lot of money on these diseases as they affect a very poor, and yet large, population."
 
Drugs that are available currently to combat these infections have big limitations. Chief among them are cost, ease of use, and toxicity. That GNF6702 may overcome these limitations and treats three diseases simultaneously gives great hope to the millions of people affected and millions more at risk for these diseases. 

Additional source: Genomics Institute of the Novartis Research Foundation, BBC
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 06, 2020
Cardiology
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
AUG 06, 2020
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
Strokes are life-changing events that can cause a myriad of issues even after it is over. Plenty of tests, such as the n ...
AUG 18, 2020
Clinical & Molecular DX
DIY COVID Tests Instead of Vaccines?
AUG 18, 2020
DIY COVID Tests Instead of Vaccines?
Routine, do-it-yourself COVID-19 testing could be just as good as a vaccine when it comes to stopping the transmission o ...
SEP 14, 2020
Clinical & Molecular DX
Peek into the Inner Workings of the Spinal Cord
SEP 14, 2020
Peek into the Inner Workings of the Spinal Cord
Scientists have established a state-of-the-art method for observing and analyzing the complex flurry of neurological act ...
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
OCT 23, 2020
Clinical & Molecular DX
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
OCT 23, 2020
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally, resulting in the loss of nearly 18 million lives each yea ...
Loading Comments...